Küronya Zsófia, Sükösd Farkas, Varga Linda, Bíró Krisztina, Gyergyay Fruzsina, Géczi Lajos, . . . Maráz Anikó. (2019). ERG expression can predict the outcome of docetaxel combined with androgen deprivation therapy in metastatic hormone-sensitive prostate cancer.
Chicago Style (17th ed.) CitationKüronya Zsófia, et al. ERG Expression Can Predict the Outcome of Docetaxel Combined with Androgen Deprivation Therapy in Metastatic Hormone-sensitive Prostate Cancer. 2019.
MLA idézésKüronya Zsófia, et al. ERG Expression Can Predict the Outcome of Docetaxel Combined with Androgen Deprivation Therapy in Metastatic Hormone-sensitive Prostate Cancer. 2019.
Figyelem: ezek az hivatkozások nem 100%-ban pontosak..